Clinical trial
A Clinical Evaluation of the Medtronic Endeavor Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries
NCT00609947 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Evaluation of the Medtronic Endeavor Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries
- Lead sponsor
- Medtronic Vascular
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- September 30, 2013
- Enrollment
- 241 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.